77 results on '"Volz Y"'
Search Results
2. The seasonality of penile fractures: Results from the GRAND study
- Author
-
Pyrgidis, N., primary, Chaloupka, M., additional, Volz, Y., additional, Pfitzinger, P., additional, Apfelbeck, M., additional, Weinhold, P., additional, Stief, C., additional, Marcon, J., additional, and Schulz, G.B., additional
- Published
- 2024
- Full Text
- View/download PDF
3. Oncological impact of perioperative blood transfusion in bladder cancer patients undergoing radical cystectomy: Do we need to consider storage time of blood units, donor age or gender matching?
- Author
-
Ebner, B., primary, Franka, F., additional, Volz, Y., additional, Eismann, L., additional, Hermans, J., additional, Buchner, A., additional, Enzinger, B., additional, Weinhold, P., additional, Wichmann, C., additional, Stief, C.G., additional, Humpe, A., additional, Pyrgidis, N., additional, and Schulz, G.B., additional
- Published
- 2024
- Full Text
- View/download PDF
4. The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: Results from the GRAND study
- Author
-
Pyrgidis, N., primary, Volz, Y., additional, Ebner, B., additional, Kazmierczak, P., additional, Enzinger, B., additional, Hermans, J., additional, Semmler, M., additional, Buchner, A., additional, Stief, C., additional, and Schulz, G.B., additional
- Published
- 2024
- Full Text
- View/download PDF
5. Aktuelle Studienlage der Enhanced Recovery After Surgery (ERAS®) nach radikaler Zystektomie
- Author
-
Schulz, G. B., Volz, Y., Jokisch, F., Casuscelli, J., Eismann, L., Pfitzinger, P., Stief, C. G., and Schlenker, B.
- Published
- 2021
- Full Text
- View/download PDF
6. Die Rolle des Mikrobioms in der Urologie
- Author
-
Magistro, G., Marcon, J., Eismann, L., Volz, Y., and Stief, C. G.
- Published
- 2020
- Full Text
- View/download PDF
7. Towards reliable diagnostics of prostate cancer via breath
- Author
-
Maiti, K. S., Fill, E., Strittmatter, F., Volz, Y., Sroka, R., and Apolonski, A.
- Published
- 2021
- Full Text
- View/download PDF
8. Health Related Quality of Life (HRQOL) four years after radical cystectomy – does the type of urinary diversion matter?
- Author
-
Volz, Y., primary, Eismann, L., additional, Paulo, P.E., additional, Westhofen, T., additional, Ebner, B.E., additional, Jokisch, J-F., additional, Schulz, G.B., additional, Schlenker, B.S., additional, Karl, A.K., additional, Stief, C.G., additional, and Kretschmer, A., additional
- Published
- 2022
- Full Text
- View/download PDF
9. Accurate diagnosis of prostate cancer via infrared spectroscopy of breath
- Author
-
Maiti, K. S., primary, Fill, E., additional, Strittmatter, F., additional, Volz, Y., additional, Sroka, R., additional, and Apolonski, A., additional
- Published
- 2021
- Full Text
- View/download PDF
10. Perioperative safety and postoperative health-related quality of life in patients receiving salvage cystectomy and urinary diversion as a last-line option for benign diseases
- Author
-
Volz, Y., primary, Eismann, L., additional, Pfitzinger, P., additional, Jokisch, J-F., additional, Schulz, G., additional, Buchner, A., additional, Schlenker, B., additional, Stief, C., additional, and Kretschmer, A., additional
- Published
- 2021
- Full Text
- View/download PDF
11. Fear of cancer recurrence in bladder cancer patients undergoing radical cystectomy with urinary diversion - Preliminary results from a prospective study (NCT04535921)
- Author
-
Volz, Y., primary, Troost, J., additional, Eismann, L., additional, Pfitzinger, P., additional, Jokisch, F., additional, Schulz, G., additional, Waidelich, R., additional, Böck, S., additional, Buchner, A., additional, Schlenker, B., additional, Stief, C., additional, and Rodler, S., additional
- Published
- 2021
- Full Text
- View/download PDF
12. A0899 - The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: Results from the GRAND study.
- Author
-
Pyrgidis, N., Volz, Y., Ebner, B., Kazmierczak, P., Enzinger, B., Hermans, J., Semmler, M., Buchner, A., Stief, C., and Schulz, G.B.
- Subjects
- *
CYSTECTOMY , *CANCER patients , *ILEAL conduit surgery , *HOSPITALS , *MORTALITY , *BLADDER cancer , *COST - Published
- 2024
- Full Text
- View/download PDF
13. Accurate diagnosis of prostate cancer via infrared spectroscopy of breath
- Author
-
Huang, Zhiwei, Lilge, Lothar D., Maiti, K. S., Fill, E., Strittmatter, F., Volz, Y., Sroka, R., and Apolonski, A.
- Published
- 2021
- Full Text
- View/download PDF
14. Accurate diagnosis of prostate cancer via infrared spectroscopy of breath.
- Author
-
Maiti, K. S., Fill, E., Strittmatter, F., Volz, Y., Sroka, R., and Apolonski, A.
- Published
- 2021
- Full Text
- View/download PDF
15. A0756 - Health Related Quality of Life (HRQOL) four years after radical cystectomy – does the type of urinary diversion matter?
- Author
-
Volz, Y., Eismann, L., Paulo, P.E., Westhofen, T., Ebner, B.E., Jokisch, J-F., Schulz, G.B., Schlenker, B.S., Karl, A.K., Stief, C.G., and Kretschmer, A.
- Subjects
- *
URINARY diversion , *CYSTECTOMY , *QUALITY of life - Published
- 2022
- Full Text
- View/download PDF
16. A0215 - The seasonality of penile fractures: Results from the GRAND study.
- Author
-
Pyrgidis, N., Chaloupka, M., Volz, Y., Pfitzinger, P., Apfelbeck, M., Weinhold, P., Stief, C., Marcon, J., and Schulz, G.B.
- Published
- 2024
- Full Text
- View/download PDF
17. P205 - Oncological impact of perioperative blood transfusion in bladder cancer patients undergoing radical cystectomy: Do we need to consider storage time of blood units, donor age or gender matching?
- Author
-
Ebner, B., Franka, F., Volz, Y., Eismann, L., Hermans, J., Buchner, A., Enzinger, B., Weinhold, P., Wichmann, C., Stief, C.G., Humpe, A., Pyrgidis, N., and Schulz, G.B.
- Subjects
- *
BLOOD transfusion , *UNITS of time , *BLADDER cancer , *RADICALS (Chemistry) , *CYSTECTOMY , *ILEAL conduit surgery - Published
- 2024
- Full Text
- View/download PDF
18. P173 - Perioperative outcomes and evolution of penile prosthesis implantation in Germany: Results from the GRAND study.
- Author
-
Pyrgidis, N., Schulz, G.B., Chaloupka, M., Volz, Y., Pfitzinger, P., Rodler, S., Berg, E., Weinhold, P., Jokisch, F., Stief, C., Becker, A., and Marcon, J.
- Subjects
- *
PENILE prostheses - Published
- 2024
- Full Text
- View/download PDF
19. A1287 - High perioperative opioid doses are associated with worse cancer-specific survival in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
- Author
-
Marcon, J., Yefsah, F., Schulz, G.B., Weinhold, P., Eismann, L., Volz, Y., Stief, C.G., Hüttl, T., Buchner, A., and Jokisch, J.F.
- Subjects
- *
TRANSITIONAL cell carcinoma , *OVERALL survival , *CYSTECTOMY , *ILEAL conduit surgery , *BLADDER , *OPIOIDS - Published
- 2023
- Full Text
- View/download PDF
20. A1234 - Adverse pathology of prostate cancer after radical prostatectomy. Summary after 7 years and 1500 patients since introduction of mpMRI-guided biopsy in a real world setting.
- Author
-
Ebner, B., Apfelbeck, M., Pyrgidis, N., Nellessen, T., Ledderose, S., Pfitzinger, P., Volz, Y., Berg, E., Abrarova, B., Rodler, S., Atzler, M., Ivanova, T., Stief, C.G., and Chaloupka, M.
- Subjects
- *
RADICAL prostatectomy , *PATHOLOGY , *BIOPSY , *PROSTATE cancer , *CANCER relapse - Published
- 2023
- Full Text
- View/download PDF
21. A1169 - Intratumoral heterogeneity of molecular subtypes in muscle-invasive bladder cancer – An extensive multi-regional immunohistochemical analysis.
- Author
-
Schallenberg, S., Dragomir, M., Anders, P., Ebner, B., Volz, Y., Eismann, L., Rodler, S., Casuscelli, J., Buchner, A., Klauschen, F., Stief, C., Horst, D., and Schulz, G.B.
- Subjects
- *
CANCER invasiveness , *IMMUNOHISTOCHEMISTRY , *BLADDER cancer , *HETEROGENEITY - Published
- 2023
- Full Text
- View/download PDF
22. Effects of Intraoperative Opioid Use and a Combined Anesthesia Protocol in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder-A Single-Center Experience.
- Author
-
Marcon J, Yefsah F, Schulz GB, Weinhold P, Rodler S, Eismann L, Volz Y, Pfitzinger PL, Stief CG, Kowalski C, Siegl D, Buchner A, Pyrgidis N, and Jokisch JF
- Abstract
Background: An increased intraoperative opioid dose seems to lead to worse outcomes in several types of cancer. We assessed the effect of intraoperatively administered opioids as well as the type of anesthesia on survival, recurrence rates and major perioperative outcomes in patients who underwent radical cystectomy (RC) for urothelial carcinoma of the urinary bladder., Methods: We included patients who underwent open RC at our center between 2015 and 2022. The role of the type and dosage of intraoperative opioid agents, such as remifentanil, sufentanil and morphine milligram equivalents (MME), as well as the type of anesthesia (intravenous only versus intravenous/epidural), was assessed regarding perioperative and long-term outcomes after RC., Results: A total of 508 patients with a median age of 73 years (IQR: 64-78) were included. Overall, 92 (18%) patients received intravenous anesthesia, whereas 416 (82%) received combined anesthesia. At a median follow-up of 270 days (IQR: 98-808), 108 (21%) deaths and 106 (21%) recurrences occurred. Combined anesthesia was associated with better survival (HR:0.63, 95% CI: 0.4-0.97, p = 0.037) and lower intensive care unit admission rates (OR: 0.49, 95% CI: 0.31-0.77, p = 0.002) in the univariate analysis (unadjusted). The type and dosage of intraoperative opioid agents did not affect long-term survival and recurrence rates, as well as major perioperative outcomes. Nevertheless, the findings of our study were limited by its single-center, retrospective design., Conclusion: The use of intraoperative opioids was not associated with worse outcomes in our cohort, while the use of additional epidural anesthesia seems to be beneficial in terms of overall survival and intensive care unit admissions. Nevertheless, further research is mandatory to validate the safety of opioids in patients undergoing RC.
- Published
- 2024
- Full Text
- View/download PDF
23. Evolution of Robotic Urology in Clinical Practice from the Beginning to Now: Results from the GRAND Study Register.
- Author
-
Pyrgidis N, Volz Y, Ebner B, Westhofen T, Staehler M, Chaloupka M, Apfelbeck M, Jokisch F, Bischoff R, Marcon J, Weinhold P, Becker A, Stief C, and Schulz GB
- Abstract
Background and Objective: Major urological guidelines do not currently recommend robot-assisted surgery compared with laparoscopic or open surgery due to the lack of high-quality evidence. We aimed to provide real-world data on the evolution of robotic urology and to compare its perioperative outcomes with those of laparoscopic and open surgeries., Methods: We used the GeRmAn Nationwide inpatient Data (GRAND), provided by the Research Data Center of the Federal Bureau of Statistics (2005-2021), and performed multiple patient-level analyses. We included patients undergoing major urological surgeries and report the largest study in the field with 993 276 patients., Key Findings and Limitations: An open approach was performed in 733 416 cases, a laparoscopic approach in 109 428, and a robot-assisted approach in 150 432. Overall, 442 811 (45%) patients underwent radical prostatectomy, 129 943 (13%) radical cystectomy, 192 340 (19%) radical nephrectomy, 123 648 (12%) partial nephrectomy, 56 114 (5.6%) nephroureterectomy, and 48 420 (4.9%) pyeloplasty. The number of patients undergoing robot-assisted surgery increased exponentially, while the number of patients undergoing open surgery decreased substantially throughout the past few years. Patients undergoing minimally invasive surgery displayed slightly better, but clinically insignificant, baseline characteristics. After adjusting for the major risk factors in the multivariate regression analysis, robotic versus open surgery was associated with significantly lower odds of mortality for all five major oncological surgeries and with lower odds of intensive care unit admission, transfusion, and length of hospital stay for all six major urological surgeries., Conclusions and Clinical Implications: Robotic surgery is becoming the mainstay in major urological operations., Patient Summary: Patients selected for robotic surgery in Germany presented better perioperative outcomes compared to those operated with an open approach., (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
24. Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data Study.
- Author
-
Pyrgidis N, Moschini M, Tzelves L, Somani BK, Juliebø-Jones P, Del Giudice F, Mertens LS, Pichler R, Volz Y, Ebner B, Eismann L, Semmler M, Pradere B, Soria F, Stief CG, and Schulz GB
- Abstract
Background: Photodynamic diagnosis (PDD) during transurethral resection of bladder tumor (TURBT) is guideline recommended, as it improves bladder cancer detection rates. However, the extent to which PDD is implemented in everyday clinical practice has not been thoroughly assessed. We aimed to evaluate the current trends and major perioperative outcomes of TURBT with PDD. Methods: The present study evaluated the GeRmAn Nationwide inpatient Data (GRAND) from 2010 (the year when PDD started to be coded separately in Germany) to 2021, which were made available from the Research Data Center of the German Bureau of Statistics. We undertook numerous patient-level and multivariable logistic regression analyses. Results: Overall, 972,208 TURBTs [228,207 (23%) with PDD and 744,001 (77%) with white light] were performed. Patients offered PDD during TURBT were younger ( p < 0.001), presented fewer comorbidities ( p < 0.001) and were discharged earlier from hospital ( p < 0.001). PDD was associated with additional costs of about EUR 500 compared to white-light TURBT ( p < 0.001). The yearly TURBT cases remained relatively stable from 2010 to 2021, whereas utilization of PDD underwent a 2-fold increase. After adjusting for major risk factors in the multivariate regression analysis, PDD was related to lower rates of transfusion (1.4% vs. 5.6%, OR: 0.29, 95% CI: 0.28 to 0.31, p < 0.001), intensive care unit admission (0.7% vs. 1.4%, OR: 0.56, 95% CI: 0.53 to 0.59, p < 0.001) and 30-day in-hospital mortality (0.1% vs. 0.7%, OR: 0.24, 95% CI: 0.22 to 0.27, p < 0.001) compared to white-light TURBT. On the contrary, PDD was related to clinically insignificant higher rates of bladder perforation (0.6% versus 0.5%, OR: 1.3, 95% CI: 1.2 to 1.4, p < 0.001), and reoperation (2.6% versus 2.3%, OR: 1.2, 95% CI: 1.1 to 1.2, p < 0.001). Conclusions: The utilization of PDD with TURBT is steadily increasing. Nevertheless, the road toward the establishment of PDD as the standard of care for TURBT is still long, despite of the advantages of PDD.
- Published
- 2024
- Full Text
- View/download PDF
25. Trends and outcomes of hospitalized patients with priapism in Germany: results from the GRAND study.
- Author
-
Pyrgidis N, Schulz GB, Chaloupka M, Volz Y, Pfitzinger PL, Berg E, Weinhold P, Jokisch F, Stief CG, Becker AJ, and Marcon J
- Abstract
We aimed to provide evidence on the trends and in-hospital outcomes of patients with low- and high-flow priapism through the largest study in the field. We used the GeRmAn Nationwide inpatient Data (GRAND), provided by the Research Data Center of the Federal Bureau of Statistics (2008-2021), and performed multiple patient-level analyses. We included 6,588 men with low-flow and 729 with high-flow priapism. Among patients with low-flow priapism, 156 (2.4%) suffered from sickle cell disease, and 1,477 (22.4%) patients required shunt surgery. Of them, only 37 (2.5%) received a concomitant penile prosthesis implantation (30 inflatable and 7 semi-rigid prosthesis). In Germany, the total number of patients with low-flow priapism requiring hospital stay has steadily increased, while the number of patients with high-flow priapism requiring hospital stay has decreased in the last years. Among patients with high-flow priapism, 136 (18.7%) required selective artery embolization. In men with low-flow priapism, sickle cell disease was associated with high rates of exchange transfusion (OR: 21, 95% CI: 14-31, p < 0.001). The length of hospital stay (p = 0.06) and the intensive care unit admissions (p = 0.9) did not differ between patients with low-flow priapism due to sickle cell disease versus other causes of low-flow priapism. Accordingly, in men with high-flow priapism, embolization was not associated with worse outcomes in terms of length of hospital stay (p > 0.9), transfusion (p = 0.8), and intensive care unit admission (p = 0.5). Low-flow priapism is an absolute emergency that requires shunt surgery in more than one-fifth of all patients requiring hospital stay. On the contrary, high-flow priapism is still managed, in most cases, conservatively., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
26. The impact of health care on outcomes of suspected testicular torsion: results from the GRAND study.
- Author
-
Pyrgidis N, Apfelbeck M, Stredele R, Rodler S, Kidess M, Volz Y, Weinhold P, Stief CG, Marcon J, Schulz GB, and Chaloupka M
- Subjects
- Humans, Male, Germany epidemiology, Adult, Adolescent, Young Adult, Treatment Outcome, Middle Aged, Child, Orchiopexy, Length of Stay statistics & numerical data, Spermatic Cord Torsion surgery, Spermatic Cord Torsion diagnosis, Spermatic Cord Torsion epidemiology, Orchiectomy statistics & numerical data
- Abstract
Background: Suspicion of testicular torsion represents a urological emergency, necessitating immediate surgery. Comprehensive data on the current trends and perioperative outcomes regarding surgical exploration are sparse. Therefore, we utilized nationwide data on the prevalence and results of this surgery, aiming to provide evidence on this matter., Methods: We assessed the GeRmAn Nationwide inpatient Data (GRAND) from 2005 to 2021, provided by the Research Data Center of the Federal Bureau of Statistics. We performed multiple regression analyses to evaluate the perioperative outcomes (length of hospital stay, transfusion, and surgical wound infection) after surgical exploration due to suspected testicular torsion based on both the outcome of surgery (orchiectomy, detorsion with preservation of the testicle, and no testicular torsion) and on the department of operation (urological versus non-urological)., Results: A total of 81,899 males underwent surgical exploration due to suspected testicular torsion in Germany from 2005 to 2021. Of them, 11,725 (14%) underwent orchiectomy, 30,765 (38%) detorsion with preservation of the testicle and subsequent orchidopexy, and 39,409 (48%) presented no testicular torsion. Orchiectomy was significantly associated with longer length of hospital stay (day difference of 1.4 days, 95%CI: 1.3-1.4, p < 0.001), higher odds of transfusion (1.8, 95% CI: 1.2-2.6, p = 0.002) and surgical wound infections (1.8, 95%CI: 1.4-2.3, p < 0.001) compared to no testicular torsion. The proportion of patients undergoing orchiectomy was significantly lower in urological departments (14%) versus non-urological departments (16%) and the proportion of patients undergoing preservation of testicle after detorsion was significantly higher in urological departments (38%) versus non-urological departments (37%), p < 0.001. Patients undergoing treatment in a urological department were discharged earlier and presented lower odds of transfusion and surgical wound infection (p < 0.001) compared to patients undergoing treatment in a non-urological department., Conclusions: Nearly half of patients who underwent surgery for suspected testicular torsion did not have intraoperatively the condition confirmed. Patients treated in urological departments had significantly better perioperative outcomes compared to those treated in non-urological departments. Therefore, we advise to refer patients to urological treatment as early as possible., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
27. Added value of randomised biopsy to multiparametric magnetic resonance imaging-targeted biopsy of the prostate in a contemporary cohort.
- Author
-
Chaloupka M, Pyrgidis N, Ebner B, Volz Y, Pfitzinger PL, Berg E, Enzinger B, Atzler M, Ivanova T, Clevert DA, Buchner A, Stief CG, and Apfelbeck M
- Subjects
- Humans, Male, Aged, Middle Aged, Ultrasonography, Interventional, Medical Overuse statistics & numerical data, Retrospective Studies, Prostatic Neoplasms pathology, Prostatic Neoplasms diagnostic imaging, Multiparametric Magnetic Resonance Imaging, Image-Guided Biopsy methods, Prostate pathology, Prostate diagnostic imaging
- Abstract
Objective: To assess the added value of concurrent systematic randomised ultrasonography-guided biopsy (SBx) to multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy and the additional rate of overdiagnosis of clinically insignificant prostate cancer (ciPCa) by SBx in a large contemporary, real-world cohort., Patients and Methods: A total of 1552 patients with positive mpMRI and consecutive mpMRI-targeted biopsy and SBx were enrolled. Added value and the rate of overdiagnosis by SBx was evaluated., Primary Outcome: added value of SBx, defined as detection rate of clinically significant PCa (csPCa; International Society of Urological Pathology [ISUP] Grade ≥2) by SBx, while mpMRI-targeted biopsy was negative or showed ciPCa (ISUP Grade 1)., Secondary Outcome: rate of overdiagnosis by SBx, defined as detection of ciPCa in patients with negative mpMRI-targeted biopsy and PSA level of <10 ng/mL., Results: Detection rate of csPCa by mpMRI-targeted biopsy and/or SBx was 753/1552 (49%). Added value of SBx was 145/944 (15%). Rate of overdiagnosis by SBx was 146/656 (22%). Added value of SBx did not change when comparing patients with previous prostate biopsy and biopsy naïve patients. In multivariable analysis, a Prostate Imaging-Reporting and Data System (PI-RADS) 4 index lesion (odds ratio [OR] 3.19, 95% confidence interval [CI] 1.66-6.78; P = 0.001), a PI-RADS 5 index lesion (OR 2.89, 95% CI 1.39-6.46; P = 0.006) and age (OR 1.05, 95% CI 1.03-1.08; P < 0.001) were independently associated with added value of SBx., Conclusions: In our real-world analysis, we saw a significant impact on added value and added rate of overdiagnosis by SBx. Subgroup analysis showed no significant decrease of added value in any evaluated risk group. Therefore, we do not endorse omitting concurrent SBx to mpMRI-guided biopsy of the prostate., (© 2023 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International.)
- Published
- 2024
- Full Text
- View/download PDF
28. The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study.
- Author
-
Pyrgidis N, Schulz GB, Volz Y, Ebner B, Rodler S, Westhofen T, Eismann L, Marcon J, Stief CG, and Jokisch F
- Subjects
- Humans, Middle Aged, Aged, Cystectomy adverse effects, Cohort Studies, Prospective Studies, Creatinine, Margins of Excision, Risk Factors, Hemoglobins, Postoperative Complications etiology, Retrospective Studies, Treatment Outcome, Urinary Bladder Neoplasms pathology, Urinary Diversion
- Abstract
Introduction: Radical cystectomy (RC) is the gold standard for muscle-invasive bladder cancer. Nevertheless, RC is associated with substantial perioperative morbidity and mortality. We aimed to evaluate the role of important perioperative risk factors in predicting long-term survival after RC., Methods: An analysis of the prospective cohort of patients undergoing open RC from 2004 to 2023 at our center was performed. Patients who died within one month after RC were excluded from the study. A univariate and multivariable Cox regression analysis was performed to assess the role of sex, age, urinary diversion, preoperative values of creatinine and hemoglobin, first-day postoperative values of CRP, leucocytes, and thrombocytes, perioperative Clavien-Dindo complications, perioperative chemotherapy, admission to the intensive or intermediate care unit, as well as type of histology, pathologic T-stage, positive lymph nodes, and positive surgical margins on predicting the long-term overall survival after RC. For all analyses hazard ratios (HRs) with the corresponding 95% confidence intervals (CIs) were estimated., Results: A total of 1,750 patients with a median age of 70 years (IQR: 62-76) were included. Of them, 1,069 (61%) received ileal conduit and 650 (37%) neobladder. Overall, 1,016 (58%) perioperative complications occurred. At a median follow-up of 31 months (IQR: 12-71), 884 (51%) deaths were recorded. In the multivariable Cox regression analysis, increasing age (HR: 1.03, 95%CI: 1.02-1.04, p < 0.001), higher preoperative creatinine values (HR: 1.27, 95%CI: 1.12-1.44, p < 0.001), lower preoperative hemoglobin values (HR: 0.93, 95%CI: 0.89-0.97, p = 0.002), higher postoperative thrombocyte values (HR: 1.01, 95%CI: 1.01-1.02, p = 0.02), Clavien-Dindo 1-2 complications (HR: 1.26, 95%CI: 1.03-1.53, p = 0.02), Clavien-Dindo 3-4 complications (HR: 1.55, 95%CI: 1.22-1.96, p < 0.001), locally advanced bladder cancer (HR: 1.29, 95%CI: 1.06-1.55, p = 0.009), positive lymph nodes (HR: 1.74, 95%CI: 1.45-2.11, p < 0.001), and positive surgical margins (HR: 1.61, 95%CI: 1.29-2.01, p < 0.001) negatively affected long-term survival., Conclusion: Beside increased age and worse oncological status, impaired renal function, lower preoperative hemoglobin values, higher postoperative thrombocyte values, and perioperative complications are independent risk factors for mortality in the long term in patients undergoing open RC., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
29. The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: results of the German nationwide inpatient data.
- Author
-
Pyrgidis N, Volz Y, Ebner B, Kazmierczak PM, Enzinger B, Hermans J, Buchner A, Stief C, and Schulz GB
- Subjects
- Humans, Inpatients, Cystectomy, Hospitals, Morbidity, Urinary Bladder Neoplasms surgery, Ileus, Sepsis epidemiology
- Abstract
Objectives: To determine a data-based optimal annual radical cystectomy (RC) hospital volume threshold and evaluate its clinical significance regarding perioperative mortality, complications, length of hospital stay, and hospital revenues., Material and Methods: We used the German Nationwide inpatient Data, provided by the Research Data Center of the Federal Bureau of Statistics (2005-2020). 95,841 patients undergoing RC were included. Based on ROC analyses, the optimal RC threshold to reduce mortality, ileus, sepsis, transfusion, hospital stay, and costs is 54, 50, 44, 44, 71 and 76 cases/year, respectively. Therefore, we defined an optimal annual hospital threshold of 50 RCs/year, and we also used the threshold of 20 RCs/year proposed by the EAU guidelines to perform multiple patient-level analyses., Results: 28,291 (29.5%) patients were operated in low- (< 20 RC/year), 49,616 (51.8%) in intermediate- (20-49 RC/year), and 17,934 (18.7%) in high-volume (≥ 50 RC/year) centers. After adjusting for major risk factors, high-volume centers were associated with lower inpatient mortality (OR 0.72, 95% CI 0.64-0.8, p < 0.001), shorter length of hospital stay (2.7 days, 95% CI 2.4-2.9, p < 0.001) and lower costs (457 Euros, 95% CI 207-707, p < 0.001) compared to low-volume centers. Patients operated in low-volume centers developed more perioperative complications such as transfusion, sepsis, and ileus., Conclusions: Centralization of RC not only improves inpatient morbidity and mortality but also reduces hospital stay and costs. We propose a threshold of 50 RCs/year for optimal outcomes., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
30. Standard operating procedure to reveal prostate cancer specific volatile organic molecules by infrared spectroscopy.
- Author
-
Maiti KS, Fill E, Strittmatter F, Volz Y, Sroka R, and Apolonski A
- Abstract
The growing number of prostate cancer cases is a real concern in modern society. Over 1.4 million new cases and about 400 thousand (>26%) deaths were registered worldwide in 2020 due to prostate cancer. The high mortality rate of prostate cancer is due to the lack of reliable early detection of the disease. Till now the most reliable diagnosis of cancer is tissue biopsy, which is an invasive process. A non-invasive or minimally invasive technique could lead to a diagnostic tool that will allow for saving or prolonging the lifespan of millions of lives. Metabolite-based diagnostics may have a better chance of early cancer detection. However, reliable detection techniques need to be developed. Infrared spectroscopy based gaseous-biofluid holds great promise towards the development of non-invasive diagnostics. A pilot study based on breath analysis by infrared spectroscopy showed promising results in distinguishing prostate cancer patients from healthy volunteers. Details of the spectral metabolic analysis are presented., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
31. Oncological impact of perioperative blood transfusion in bladder cancer patients undergoing radical cystectomy: Do we need to consider storage time of blood units, donor age, or gender matching?
- Author
-
Ebner B, Fleckenstein F, Volz Y, Eismann L, Hermans J, Buchner A, Enzinger B, Weinhold P, Wichmann C, Stief CG, Humpe A, Pyrgidis N, and Schulz GB
- Subjects
- Humans, Retrospective Studies, Blood Transfusion, Prognosis, Treatment Outcome, Cystectomy, Urinary Bladder Neoplasms surgery
- Abstract
Background: The oncological impact of perioperative blood transfusions (PBTs) of patients undergoing radical cystectomy (RC) because of bladder cancer (BCa) has been a controversial topic discussed in recent years. The main cause for the contradictory findings of existing studies might be the missing consideration of the storage time of red blood cell units (BUs), donor age, and gender matching., Study Design and Methods: We retrospectively analyzed BCa patients who underwent RC in our department between 2004 and 2021. We excluded patients receiving BUs before RC, >10 BUs, or RC in a palliative setting. We assessed the effect of blood donor characteristics and storage time on overall survival (OS) and cancer-specific survival (CSS) through univariate and multivariable Cox regression analysis. We also performed a propensity score matching with patients who received BUs and patients who did not on a 1:1 ratio., Results: We screened 1692 patients and included 676 patients for the propensity score matching. In the multivariable analysis, PBT was independently associated with worse OS and CSS (p < .001). Postoperative transfusions were associated with better OS (p = .004) and CSS (p = .008) compared to intraoperative or mixed transfusions. However, there was no influence of blood donor age, storage time, or gender matching on prognosis., Discussion: In our study of BCa patients undergoing RC, we demonstrate that PBT, especially if administered intraoperatively, is an independent risk factor for a worse prognosis. However, storage time, donor age, or gender matching did not negatively affect oncological outcomes. Therefore, the specific selection of blood products does not promise any benefits., (© 2023 The Authors. Transfusion published by Wiley Periodicals LLC on behalf of AABB.)
- Published
- 2024
- Full Text
- View/download PDF
32. The Prognostic Value of Perioperative Platelet and Leukocyte Values in Patients Undergoing Radical Cystectomy: A Prospective Long-Term Cohort Study.
- Author
-
Pyrgidis N, Schulz GB, Volz Y, Ebner B, Rodler S, Westhofen T, Eismann L, Marcon J, Stief CG, and Jokisch F
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Prospective Studies, Prognosis, Platelet Count, Time Factors, Leukocyte Count, Leukocytosis blood, Thrombocytosis blood, Perioperative Period, Cohort Studies, Survival Rate, Cystectomy adverse effects, Urinary Bladder Neoplasms surgery, Urinary Bladder Neoplasms mortality, Urinary Bladder Neoplasms blood
- Abstract
Introduction: Studies assessing the impact of preoperative and first-day postoperative values of leukocytes, thrombocytes, and platelet/leukocyte ratio (PLR) after radical cystectomy (RC) are sparse. We aimed to assess the impact of these factors on long-term survival after RC., Methods: An analysis of patients undergoing open RC from 2004 to 2023 at our center was performed. Leukocytosis was defined as ≥8,000 leukocytes/μL and thrombocytosis as ≥400,000 thrombocytes/μL. Similarly, the cutoff for PLR was set at 28. A multivariable Cox regression analysis was performed to assess the role of leukocytosis, thrombocytosis, and PLR on long-term survival after RC. For all analyses, hazard ratios (HRs) with the corresponding 95% confidence intervals (CIs) were estimated., Results: A total of 1,817 patients with a median age of 70 years (interquartile range [IQR]: 62-77) were included. Overall, 804 (44%), 175 (10%), and 1,296 (71%) patients presented with leukocytosis, thrombocytosis, and PLR ≥28 preoperatively. Accordingly, 1,414 (78%), 37 (2%), and 249 (14%) patients presented with leukocytosis, thrombocytosis, and PLR ≥28 on the first day after RC. At a median follow-up of 26 months (IQR: 8-68) after RC, 896 (49%) patients died. In the multivariate Cox regression analysis after adjusting for major perioperative risk factors, only preoperative leukocytosis (HR: 1.3, 95% CI: 1.1-1.6, p = 0.01), as well as both preoperative and first-day thrombocytosis (HR: 2.1, 95% CI: 1.5-2.9, and HR: 2.8, 95% CI: 1.6-5.1, p < 0.001, accordingly) were associated with worse overall survival., Conclusion: PLR should not be used as a prognostic marker for survival after RC. On the contrary, preoperative leukocytosis, as well as preoperative and first-day thrombocytosis should raise awareness among clinicians performing RC since they were independently associated with worse survival after RC., (© 2024 S. Karger AG, Basel.)
- Published
- 2024
- Full Text
- View/download PDF
33. Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?
- Author
-
Volz Y, Trappmann R, Ebner B, Eismann L, Enzinger B, Hermans J, Pyrgidis N, Stief C, and Schulz GB
- Subjects
- Humans, Neoplasm Recurrence, Local pathology, Retrospective Studies, Urinary Bladder surgery, Urinary Bladder pathology, Urologic Surgical Procedures, Urinary Bladder Neoplasms pathology, Non-Muscle Invasive Bladder Neoplasms pathology, Non-Muscle Invasive Bladder Neoplasms surgery, Transurethral Resection of Bladder
- Abstract
Introduction: Transurethral resection of the bladder (TUR-BT) is the standard initial treatment and diagnosis of bladder cancer (BC). Of note, upstaging into muscle-invasive disease (MIBC) during re-resection occurs in a significant proportion of patients. This study aimed to define risk factors at initial TUR-BT for upstaging., Methods: TUR-BT between 2009 and 2021 were retrospectively screened (n = 3,237). We included patients with visible tumors that received their primary and re-TUR-BT at our institution. Upstaging was defined as pathological tumor stage progression into MIBC at re-TUR-BT. Clinicopathological variables were analyzed for the impact on upstaging., Results: Two hundred and sixty-six patients/532 TUR-BTs were included in the final analysis. Upstaging occurred in 7.9% (21/266) patients. Patients with upstaging presented with stroma-invasive and papillary non-muscle-invasive BC at primary resection in 85.7% (18/21) and 14.3% (3/21), respectively. Detrusor muscle at primary TUR-BT was significantly less present in patients with upstaging (4.1 vs. 95.9%; p < 0.001). After multivariate analysis, solid tumor configuration (HR: 4.17; 95% CI: 1.23-14.15; p = 0.022) and missing detrusor muscle at initial TUR-BT (HR: 3.58; 95% CI: 1.05-12.24; p = 0.043) were significant risk factors for upstaging into MIBC., Conclusions: The current study defined two major risk factors for upstaging: missing detrusor muscle and solid tumor configuration. We propose that a second resection should be performed earlier if these risk factors apply., (© 2023 S. Karger AG, Basel.)
- Published
- 2024
- Full Text
- View/download PDF
34. mpMRI-targeted biopsy of the prostate in men ≥ 75 years. 7-year report from a high-volume referral center.
- Author
-
Chaloupka M, Pyrgidis N, Ebner B, Pfitzinger PL, Volz Y, Berg E, Enzinger B, Atzler M, Ivanova T, Pfitzinger PL, Stief CG, Apfelbeck M, and Clevert DA
- Subjects
- Male, Humans, Aged, Prostate diagnostic imaging, Prostate pathology, Prostate-Specific Antigen, Magnetic Resonance Imaging methods, Biopsy, Referral and Consultation, Image-Guided Biopsy methods, Retrospective Studies, Multiparametric Magnetic Resonance Imaging, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms pathology
- Abstract
Objective: Multiparametric magnetic resonance imaging (mpMRI) -Ultrasound- fusion guided biopsy of the prostate (FBx) is the new gold standard for the detection of prostate cancer. Hallmark studies showing superior detection rates of FBx over randomized biopsies routinely excluded patients≥75 years and information on outcome of FBx on this patient cohort is sparse. As a large referral center, we have performed FBx on a substantial number of patients this age. By evaluating outcome of FBx of patients over the age of 75 years we wanted to close the gap of knowledge on this patient cohort., Materials and Methods: Between 2015 -2022, 1577 patients underwent FBx at our department and were considered for analysis. Clinical and histopathological parameters were recorded. Clinical data comprised age at FBx, serum level of Prostate-specific antigen (PSA), prostate volume, PSA-density, history of previous biopsies of the prostate, result of the digital rectal examination (DRE) and assessment of the indexlesion of mpMRI according to the Prostate Imaging and Reporting Data System (PI-RADS). Univariate analysis and multivariable logistic regression was used to identify age barrier of 75 years as a potential risk factor of detection of clinically significant prostate cancer by FBx., Results: 379/1577 patients (24%) were≥75 years and 1198/1577 (76%) patients were < 75 years, respectively. Preoperative PSA was significantly higher in patients≥75 years compared to patients < 75 years (9.54 vs. 7.8, p < 0.001). Patients≥75 years presented significantly more often with mpMRI target lesions classified as PI-RADS 5 compared to patients < 75 years (45% vs. 29%, p < 0.001). Detection rate of clinically significant prostate cancer was significantly higher in patients≥75 years compared to patients < 75 years (63% vs. 43%, p < 0.001). Aggressive prostate cancer grade ISUP 5 was significantly more often detected in patients≥75 years compared to patients < 75 years (13% vs. 8%, p = 0.03). On multivariable logistic regression model adjusted for PSA and PI-RADS score, age barrier of 75 years was identified as a significant risk factor for the detection of clinically significant prostate cancer by FBx (OR: 1.77, 95% CI: 1.36 -2.31, p < 0.001)., Conclusion: After evaluation of a large patient cohort, we show that age≥75 years represents a significant risk factor for the detection of clinically significant prostate cancer. Further studies on mid- and long term outcome are necessary to draw conclusions for clinical decision making in this patient cohort.
- Published
- 2024
- Full Text
- View/download PDF
35. Penile fractures: the price of a merry Christmas.
- Author
-
Pyrgidis N, Chaloupka M, Volz Y, Pfitzinger P, Apfelbeck M, Weinhold P, Stief C, Marcon J, and Schulz GB
- Subjects
- Humans, Adult, Middle Aged, Risk Factors, Incidence, Hospitals, Pandemics, Hospitalization
- Abstract
Objectives: To explore whether Christmas might be a risk factor for penile fractures due to the Christmas spirit related to the intimacy and euphoria of these holly jolly days., Patients and Methods: We evaluated the incidence of penile fractures during Christmas and New Year's Eve through the GeRmAn Nationwide inpatient Data (GRAND) from the Research Data Center of the Federal Bureau of Statistics (Wiesbaden, Germany). Furthermore, we assessed the impact of COVID-19 on penile fractures and their seasonality., Results: A total of 3,421 patients with a median, interquartile range (IQR) age of 42 (32-51) years had a penile fracture requiring a hospital stay from 2005 to 2021. In all, 40 (1.2%) penile fractures occurred in 51 days of Christmas (from 24/12 to 26/12 in each year). The daily incidence of penile fractures during Christmas was 0.78 with an incidence rate ratio (IRR) of 1.43 (95% confidence interval [CI] 1.05-1.95, P = 0.02). If every day was like Christmas, 43% more penile fractures would have occurred in Germany from 2005 on. Interestingly, only 28 (0.82%) penile fractures occurred during the New Year's Eve period (31/12 to 02/01 from 2005 to 2021). This resulted in an IRR of 0.98 (95% CI 0.69-1.5, P = 0.98) in the New Year's Eve period. Most patients with penile fractures were admitted to hospital at the weekend (n = 1,322; IRR 1.58, 95% CI 1.48-1.69; P < 0.001). Summer was also associated with more penile fractures (n = 929; IRR 1.11, 95% CI 1.03-1.19; P = 0.008). Both the COVID-19 pandemic (n = 385; IRR 1.06, 95% CI 0.95-1.18, P = 0.29) and its lockdown period (n = 93; IRR 1, 95% CI 0.82-1.23; P = 0.96) did not affect the incidence of penile fractures., Conclusion: The incidence of penile fractures displays a seasonality. Last Christmas penile fractures occurred more often. This year to save us from tears, we will NOT do something special (the new Christmas hit of the year)., (© 2023 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International.)
- Published
- 2023
- Full Text
- View/download PDF
36. Perioperative outcomes of penile prosthesis implantation in Germany: results from the GRAND study.
- Author
-
Pyrgidis N, Schulz GB, Chaloupka M, Volz Y, Pfitzinger PL, Rodler S, Berg E, Weinhold P, Jokisch F, Stief CG, Becker AJ, and Marcon J
- Abstract
We aimed to assess the recommended annual hospital volume for inflatable penile prosthesis implantation (PPI) and to provide evidence on perioperative outcomes of semi-rigid and inflatable PPI in Germany. We used the GeRmAn Nationwide inpatient Data (GRAND) from 2005 to 2021 and report the largest study to date with 7,222 patients. 6,818 (94.4%) patients underwent inflatable and 404 (5.6%) semi-rigid PPI. Inflatable PPI was significantly associated with shorter length of hospital stay (difference of 2.2 days, 95%CI: 1.6-2.7, p < 0.001), lower odds of perioperative urinary tract infections (5.5% versus 9.2%; OR: 0.58, 95%CI: 0.41-0.84, p = 0.003) and surgical wound infections (1% versus 2.5%; OR: 0.42, 95%CI: 0.22-0.88, p = 0.012) compared to semi-rigid PPI. Overall, 4255 (62.4%) inflatable PPIs were undertaken in low- ( < 20 PPI/year) and 2563 (37.6%) in high-volume ( ≥ 20 PPI/year) centers. High-volume centers were significantly associated with shorter length of hospital stay (difference of 1.4 days, 95%CI: 1.2-1.7, p < 0.001) compared to low-volume centers. Our findings suggest that inflatable PPI leads to a shorter length of hospital stay and lower rates of perioperative urinary tract and surgical wound infections compared to semi-rigid PPI. Patients undergoing surgery in high-volume centers for inflatable PPI are discharged earlier from the hospital., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
37. Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis.
- Author
-
Schallenberg S, Dragomir MP, Anders P, Ebner B, Volz Y, Eismann L, Rodler S, Casuscelli J, Buchner A, Klauschen F, Stief C, Horst D, and Schulz GB
- Subjects
- Humans, Urinary Bladder pathology, Prognosis, Gene Expression Profiling methods, Muscles pathology, Urinary Bladder Neoplasms genetics, Urinary Bladder Neoplasms surgery, Urinary Bladder Neoplasms pathology
- Abstract
Background: Molecular bladder cancer (BC) subtypes define distinct biological entities and were shown to predict treatment response in neoadjuvant and adjuvant settings. The extent of intratumoral heterogeneity (ITH) might affect subtyping of individual patients., Objective: To comprehensively assess the ITH of molecular subtypes in a cohort of muscle-invasive BC., Design, Setting, and Participants: A total of 251 patients undergoing radical cystectomy were screened. Three cores of the tumor center (TC) and three cores of the invasive tumor front (TF) of each patient were assembled in a tissue microarray. Molecular subtypes were determined employing 12 pre-evaluated immunohistochemical markers (FGFR3, CCND1, RB1, CDKN2A, KRT5, KRT14, FOXA1, GATA3, TUBB2B, EPCAM, CDH1, and vimentin). A total of 18 072 spots were evaluated, of which 15 002 spots were assessed based on intensity, distribution, or combination., Outcome Measurements and Statistical Analysis: Allocation to one of five different molecular subtypes-urothelial like, genomically unstable, small-cell/neuroendocrine like, basal/squamous cell carcinoma like, and mesenchymal like-was conducted for each patient for the complete tumor, individual cores, TF, and TC separately. The primary objective was to assess the ITH between the TF and TC (n = 208 patients). The secondary objective was the evaluation of multiregion ITH (n = 191 patients). An analysis of the composition of ITH cases, association with clinicopathological parameters, and prognosis was conducted., Results and Limitations: ITH between the TF and TC was seen in 12.5% (n = 26/208), and ITH defined by at least two different subtypes of any location was seen in 24.6% (n = 47/191). ITH was more frequent in locally confined (pT2) versus advanced (pT ≥3) BC stages (38.7% vs 21.9%, p = 0.046), and pT4 BC presented with significantly more basal subtypes than pT2 BC (26.2% vs 11.5%, p = 0.049). In our cohort, there was no association of subtype ITH with prognosis or accumulation of specific molecular subtypes in ITH cases. The key limitations were missing transcriptomic and mutational genetic validation as well as investigation of ITH beyond subtypes., Conclusions: Several molecular subtypes can be found in nearly every fourth case of muscle-invasive BC, when using immunohistochemistry. ITH must be given due consideration for subtype-guided strategies in BC. Genomic validation of these results is needed., Patient Summary: Different molecular subtypes can be found in many cases of muscle-invasive bladder cancer. This might have implications for individualized, subtype-based therapeutic approaches., (Copyright © 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
38. The Impact of Prostate Volume on the Prostate Imaging and Reporting Data System (PI-RADS) in a Real-World Setting.
- Author
-
Volz Y, Apfelbeck M, Pyrgidis N, Pfitzinger PL, Berg E, Ebner B, Enzinger B, Ivanova T, Atzler M, Kazmierczak PM, Clevert DA, Stief C, and Chaloupka M
- Abstract
Multiparametric magnetic resonance imaging (mpMRI) has emerged as a new cornerstone in the diagnostic pathway of prostate cancer. However, mpMRI is not devoid of factors influencing its detection rate of clinically significant prostate cancer (csPCa). Amongst others, prostate volume has been demonstrated to influence the detection rates of csPCa. Particularly, increasing volume has been linked to a reduced cancer detection rate. However, information about the linkage between PI-RADS, prostate volume and detection rate is relatively sparse. Therefore, the current study aims to assess the association between prostate volume, PI-RADS score and detection rate of csP-Ca, representing daily practice and contemporary mpMRI expertise. Thus, 1039 consecutive patients with 1151 PI-RADS targets, who underwent mpMRI-guided prostate biopsy at our tertiary referral center, were included. Prior mpMRI had been assessed by a plethora of 111 radiology offices, including academic centers and private practices. mpMRI was not secondarily reviewed in house before biopsy. mpMRI-targeted biopsy was performed by a small group of a total of ten urologists, who had performed at least 100 previous biopsies. Using ROC analysis, we defined cut-off values of prostate volume for each PI-RADS score, where the detection rate drops significantly. For PI-RADS 4 lesions, we found a volume > 61.5 ccm significantly reduced the cancer detection rate (OR 0.24; 95% CI 0.16-0.38; p < 0.001). For PI-RADS 5 lesions, we found a volume > 51.5 ccm to significantly reduce the cancer detection rate (OR 0.39; 95% CI 0.25-0.62; p < 0.001). For PI-RADS 3 lesions, none of the evaluated clinical parameters had a significant impact on the detection rate of csPCa. In conclusion, we show that enlarged prostate volume represents a major limitation in the daily practice of mpMRI-targeted biopsy. This study is the first to define exact cut-off values of prostate volume to significantly impair the validity of PI-RADS assessed in a real-world setting. Therefore, the results of mpMRI-targeted biopsy should be interpreted carefully, especially in patients with prostate volumes above our defined thresholds.
- Published
- 2023
- Full Text
- View/download PDF
39. Absence of detrusor muscle in TUR-BT specimen - can we predict who is at highest risk?
- Author
-
Volz Y, Trappmann R, Ebner B, Eismann L, Pyrgidis N, Pfitzinger P, Bischoff R, Schlenker B, Stief C, and Schulz GB
- Subjects
- Humans, Retrospective Studies, Urologic Surgical Procedures, Prognosis, Muscles pathology, Neoplasm Recurrence, Local pathology, Urinary Bladder Neoplasms pathology
- Abstract
Introduction: As a high-quality TUR-BT is important to ensure adequate treatment for bladder cancer patients, the aim of the current study is to investigate the impact of patient-related, surgical and tumor-specific parameters on detrusor muscle (DM) absence (primary objective) and to assess the impact of DM on the prognosis after a TUR-BT (secondary objective)., Patients and Methods: Transurethral resection of bladder tumors (TUR-BTs) between 2009 and 2021 were retrospectively screened (n = 3237). We included 2058 cases (1472 patients) for the primary and 472 patients for secondary objective. Clinicopathological variables including tumor size, localization, multifocality, configuration, operation time and skill-level of the urologist were assessed. We analyzed predictors for missing DM and prognostic factors for recurrence-free survival (RFS) for the complete cohort and subgroups., Results: DM was present in 67.6% (n = 1371/2058). Surgery duration (continuous, minutes) was an independent predictor for absence of DM in the complete cohort (OR:0.98, r:0.012, 95%CI:0.98-0.99, p = 0.001). Other significant risk factors for missing DM were papillary tumors (OR:1.99, r:0.251, 95%CI:1.22-3.27, p = 0.006) in the complete cohort and bladder-roof and posterior-bladder-wall localization for re-resections. Absence of DM in high-grade BC correlated with reduced RFS (HR:1.96, 95%CI:1.0-3.79, p = 0.045)., Conclusion: Sufficient time for a TUR-BT is mandatory to assure DM in the TUR-BT specimen. Also, cases with more difficult locations of bladder tumors should be performed with utmost surgical diligence and endourological training should incorporate how to perform such operations. Of note, DM correlates with improved oncological prognosis in high-grade BC., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
40. [Common errors, pitfalls, and management of complications of prostate biopsy : The most common diagnostic and procedural challenges of transrectal fusion prostate biopsy in the initial diagnosis of clinically significant prostate cancer].
- Author
-
Enzinger B, Pfitzinger PL, Ebner B, Ivanova T, Volz Y, Apfelbeck M, Kazmierczak P, Stief C, and Chaloupka M
- Subjects
- Male, Humans, Rectum diagnostic imaging, Retrospective Studies, Prospective Studies, Image-Guided Biopsy adverse effects, Prostate diagnostic imaging, Prostatic Neoplasms diagnosis
- Abstract
Background: Transrectal (TR) prostate biopsy is the gold standard in diagnosis of prostate cancer (PC). It requires a precise and safe technique for sample acquisition., Objective: Several approaches will be discussed to avoid overdiagnosis, false-negative results, and complications of the procedure., Materials and Methods: We analyzed national and European guidelines, systematic reviews, meta-analyses, as well as prospective and retrospective studies to describe current trends in indication and performance of biopsies., Results: Incorporation of risk calculators and magnetic resonance imaging (MRI) into daily routine reduces biopsy rates and results in a more precise diagnosis of clinically significant prostate cancer (csPC). Combination of random- and MRI-fusion guided biopsy-but also extending the radius of sampling by 10 mm beyond the MRI lesion and a transperineal (TP) sampling approach - lead to a higher tumor-detection rate. Bleeding is the most common complication after prostate biopsy and is usually self-limiting. Postbiopsy infection rates can be reduced through TP biopsy., Conclusion: TR MRI-fusion guided biopsy is a widely acknowledged tool in primary diagnostics of csPC. Higher detection rates and safety can be achieved through a TP sampling approach., (© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
41. [Transrectal vs. transperineal fusion biopsy of the prostate : Time to switch to the perineal technique-comparison of methods and description of the transperineal procedure under local anesthesia].
- Author
-
Pfitzinger PL, Enzinger B, Ebner B, Ivanova T, Volz Y, Chaloupka M, Apfelbeck M, and Stief C
- Subjects
- Male, Humans, Anesthesia, Local, Ultrasonography, Interventional methods, Image-Guided Biopsy methods, Prostate diagnostic imaging, Prostatic Neoplasms diagnostic imaging
- Abstract
The clinical and histological diagnosis of prostate cancer is a crucial aspect of the routine work of a urologist. The high prevalence of multiresistant microorganisms leads to an increased incidence of sepsis after transrectal prostate biopsy. It requires a switch from the still gold-standard method to the transperineal fusion biopsy procedure after multiparametric prostate magnetic resonance imaging (MRI). This article provides an overview of the most important differences between the two methods and gives a detailed methodological description of transperineal fusion biopsy under local anesthesia., (© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
42. Adverse Pathology after Radical Prostatectomy of Patients Eligible for Active Surveillance-A Summary 7 Years after Introducing mpMRI-Guided Biopsy in a Real-World Setting.
- Author
-
Ebner B, Apfelbeck M, Pyrgidis N, Nellessen T, Ledderose S, Pfitzinger PL, Volz Y, Berg E, Enzinger B, Rodler S, Atzler M, Ivanova T, Clevert DA, Stief CG, and Chaloupka M
- Abstract
Objective: Over the last decade, active surveillance (AS) of low-risk prostate cancer has been increasing. The mpMRI fusion-guided biopsy of the prostate (FBx) is considered to be the gold standard in preoperative risk stratification. However, the role of FBx remains unclear in terms of risk stratification of low-risk prostate cancer outside high-volume centers. The aim of this study was to evaluate adverse pathology after radical prostatectomy (RP) in a real-world setting, focusing on patients diagnosed with Gleason score (GS) 6 prostate cancer (PCa) and eligible for AS by FBx., Subjects and Methods: Between March 2015 and March 2022, 1297 patients underwent FBx at the Department of Urology, Ludwig-Maximilians-University of Munich, Germany. MpMRI for FBx was performed by 111 different radiology centers. FBx was performed by 14 urologists from our department with different levels of experience. In total, 997/1297 (77%) patients were diagnosed with prostate cancer; 492/997 (49%) of these patients decided to undergo RP in our clinic and were retrospectively included. Univariate and multivariable logistic regression analyses were performed to evaluate clinical and histopathological parameters associated with adverse pathology comparing FBx and RP specimens. To compare FBx and systematic randomized biopsies performed in our clinic before introducing FBx (SBx, n = 2309), we performed a propensity score matching on a 1:1 ratio, adjusting for age, number of positive biopsy cores, and initial PSA (iPSA)., Results: A total of 492 patients undergoing FBx or SBx was matched. In total, 55% of patients diagnosed with GS 6 by FBx were upgraded to clinically significant PCa (defined as GS ≥ 7a) after RP, compared to 52% of patients diagnosed by SBx ( p = 0.76). A time delay between FBx and RP was identified as the only correlate associated with upgrading. A total of 5.9% of all FBx patients and 6.1% of all SBx patients would have been eligible for AS ( p > 0.99) but decided to undergo RP. The positive predictive value of AS eligibility (diagnosis of low-risk PCa after biopsy and after RP) was 17% for FBx and 6.7% for SBx ( p = 0.39)., Conclusions: In this study, we show, in a real-world setting, that introducing FBx did not lead to significant change in ratio of adverse pathology for low-risk PCa patients after RP compared to SBx.
- Published
- 2023
- Full Text
- View/download PDF
43. Age and ECOG Performance Status as Predictors of Survival of Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
- Author
-
Eismann L, Bohn L, Buchner A, Casuscelli J, Volz Y, Weinhold P, Wülfing C, Waidelich R, Stief CG, Schlenker B, and Rodler S
- Subjects
- Humans, Aged, Nephroureterectomy, Retrospective Studies, Treatment Outcome, Carcinoma, Transitional Cell surgery, Urinary Bladder Neoplasms surgery, Ureteral Neoplasms surgery, Kidney Neoplasms surgery, Urinary Tract
- Abstract
Introduction: This study aimed to evaluate the impact of chronological and biological age on perioperative complications and survival after radical nephroureterectomy (RNU). Elderly patients with upper-tract urothelial carcinoma might be overtreated by RNU., Methods: We retrospectively analyzed patients undergoing RNU. To evaluate the perioperative risk, patients were divided into four groups (<75; 75-79; 80-84; ≥85 years). The endpoints are perioperative complications and survival (overall survival [OS]). We calculated a risk score including chronological and biological age (Eastern cooperative oncology group performance status). Statistical analysis was performed by Kruskal-Wallis, Mann-Whitney U, χ2, log-rank, and Breslow tests., Results: 194 patients were included in the study. Median follow-up was 25.5 months. Elderly cohorts ≥2 presented a higher number of days in intensive care unit following RNU (p < 0.001). Complication rates increased from cohort 1-4 with rates of 48.8%; 55.2%; 92.0%; 85.7% (p < 0.001). Median survival was 115, 55, 28, and 20 months for cohorts 1, 2, 3, and 4, respectively. The combined risk score revealed a significant 5-year OS benefit for patients with score 0 (82.3%) compared to score 1 (46.0%) and score 2 (15.0%; p < 0.001)., Discussion/conclusion: We evaluated the impact of chronological and biological age on perioperative complications and survival after RNU. A combined risk score of chronological and biological age correlates with survival after RNU., (© 2022 S. Karger AG, Basel.)
- Published
- 2023
- Full Text
- View/download PDF
44. Asymptomatic bacteriospermia and infertility-what is the connection?
- Author
-
Volz Y, Ebner B, Pfitzinger P, Berg E, Lellig E, Marcon J, Trottmann M, Becker A, Stief CG, and Magistro G
- Subjects
- Humans, Male, Semen, Retrospective Studies, Cohort Studies, Coagulase, Enterococcus faecalis, Staphylococcus, Semen Analysis, Infertility, Male microbiology
- Abstract
Objective: To determine the impact of asymptomatic bacteriospermia on semen quality in subfertile men., Methods: We conducted a retrospective, single-centre cohort study in 1300 subfertile men. In those diagnosed with asymptomatic bacteriospermia we performed univariate and multivariate logistic regression models to evaluate the strain-specific association with semen parameters., Results: Asymptomatic bacteriospermia was diagnosed in 3.2% of patients. The microbiological semen analysis revealed a poly-microbial result in 60%. The most common bacterial species were coagulase-negative Staphylococci species (71.4%), Streptococcus viridans (50.0%) and Enterococcus faecalis (26.2%). Sexually transmitted pathogens were identified in 11.9% of semen samples. The detection of Streptococcus viridians or Haemophilus parainfluenzae correlated with impaired sperm morphology (p < 0.05). The presence of coagulase-negative Staphylococci species or Enterococcus faecalis was associated with pathological low counts of live spermatozoa (p < 0.05). In multivariate analysis only Enterococcus faecalis showed a significant impact on sperm concentration (OR 4.48; 95% CI 1.06-22.10; p = 0.041)., Conclusions: Asymptomatic bacteriospermia has always been a subject of great controversy. There is still an ongoing debate whether to treat or not to treat. Here, we demonstrate that asymptomatic bacteriospermia is clearly associated with impaired semen quality. Our findings speak in favour of strain-specific interactions with semen parameters. Especially Enterococcus faecalis seriously affects sperm concentration., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
45. Identification of the Tumor Infiltrating Lymphocytes (TILs) Landscape in Pure Squamous Cell Carcinoma of the Bladder.
- Author
-
Eismann L, Rodler S, Buchner A, Schulz GB, Volz Y, Bischoff R, Ebner B, Westhofen T, Casuscelli J, Waidelich R, Stief C, Schlenker B, and Ledderose S
- Abstract
Background: Tumor infiltrating lymphocytes (TILs) are known as important prognostic biomarkers and build the fundament for immunotherapy. However, the presence of TILs and its impact on outcome in pure squamous cell carcinoma (SCC) of the bladder remains uncertain. Methods: Out of 1600 patients undergoing radical cystectomy, 61 patients revealed pure bladder SCC in the final histopathological specimen. Retrospectively, immunohistochemical staining was performed on a subset of TILs (CD3+, CD4+, CD8+, CD20+). Endpoints were overall survival (OS), cancer-specific survival (CSS) and progression-free survival (PFS). The Kaplan−Meier method was used to evaluate survival outcomes. Results: Strong infiltration of CD3+ was found in 27 (44%); of CD4+ in 28 (46%); of CD8+ in 26 (43%); and of CD20+ in 27 tumors (44%). Improved OS was observed for strong CD3+ (p < 0.001); CD4+ (p = 0.045); CD8+ (p = 0.001); and CD20+ infiltration (p < 0.001). Increased rates of PFS were observed for CD3+ (p = 0.025) and CD20+ TILs (p = 0.002). In multivariate analyses, strong CD3+ (HR: 0.163, CI: 0.044−0.614) and strong CD8+ TILs (HR: 0.265, CI: 0.081−0.864) were revealed as predictors for OS and the strong infiltration of CD20+ cells (HR: 0.095, CI: 0.019−0.464) for PFS. Conclusions: These first results of TILs in bladder SCC revealed predictive values of CD3+, CD8+ and CD20+.
- Published
- 2022
- Full Text
- View/download PDF
46. Long-term Health-related Quality of Life (HRQOL) After Radical Cystectomy and Urinary Diversion - A Propensity Score-matched Analysis.
- Author
-
Volz Y, Eismann L, Pfitzinger P, Westhofen T, Ebner B, Jokisch JF, Buchner A, Schulz GB, Schlenker B, Karl A, Stief CG, and Kretschmer A
- Subjects
- Cystectomy methods, Humans, Propensity Score, Quality of Life, Urinary Bladder pathology, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms surgery, Urinary Diversion, Urinary Reservoirs, Continent pathology
- Abstract
Introduction: Radical cystectomy (RC) and urinary diversion by ileal conduit (IC) or ileal orthotopic neobladder (ONB) is the standard-of-care for surgical treatment of muscle-invasive bladder cancer. Yet, it is unclear how urinary diversion affects the patient's health-related quality of life (HRQOL) in the longer-term., Methods: HRQOL was assessed preoperatively, 3mo postoperatively and then annually until a maximum follow-up of 48 months using the validated EORTC QLQ-C30- as well as the bladder cancer-specific FACT-BL- and QLQ-BLM30-questionnaires. A propensity-score matching for the variables "age," "ASA-classification," "cardiovascular co-morbidity," "sex" as well as "tumor stage," and "preoperative physical functioning score" was performed. Hypothetical predictors for decreased general HRQOL were analyzed using multivariable logistic regression models., Results: After propensity-score matching, 246 patients were analyzed. HRQOL assessment revealed significant differences regarding preoperative QLQ-C30 symptoms which diminished during the postoperative time course. Similarly, we did not find significant differences based on bladder cancer-specific FACT-BL and QLQ-BLM HRQOL assessment including body image (48 months: 29.6.4 [IC] vs. 40.7 [ONB]; P = .733). Regarding general HRQOL, we found increased global health status scores for ONB throughout the whole observational period without reaching statistical significance (48 months: 55.0 [IC] vs. 70.1 [ONB]; P = .079). In multivariate analysis, cardiovascular comorbidity was an independent predictor of impaired HRQOL 24 months (HR 2.20; CI95% 1.02-5.72, P = .044) and 36 months (HR 6.84; CI95% 1.61-29.14, P = .009) postoperatively., Conclusion: We did not observe significant differences in bladder-specific as well as generic HRQOL in the longer-term and consequently, the type of urinary diversion was not an independent predictor of good general HRQOL in a follow-up period of 4 years., Competing Interests: Disclosure The authors report no conflict of interest., (Copyright © 2022. Published by Elsevier Inc.)
- Published
- 2022
- Full Text
- View/download PDF
47. Accuracy and prognostic value of radiological lymph node features in variant histologies of bladder cancer.
- Author
-
Rodler S, Solyanik O, Ingenerf M, Fabritius M, Schulz GB, Jokisch F, Volz Y, Westhofen T, Ebner B, Casuscelli J, Kretschmer A, Waidelich R, Schlenker B, Stief C, Buchner A, and Eismann L
- Subjects
- Humans, Lymph Nodes pathology, Lymphatic Metastasis diagnostic imaging, Lymphatic Metastasis pathology, Neoplasm Staging, Prognosis, Tomography, X-Ray Computed, Urinary Bladder Neoplasms pathology
- Abstract
Purpose: To provide first evidence of lymph node (LN) staging using CT scan and its prognostic value in variant histologies of bladder cancer. This knowledge may optimize patient management with variant histologies based on CT morphological findings., Methods: Preoperative CT scans of patients with variant histologies who underwent RC between 2004 and 2019 were reanalyzed by two independent radiologists in a blinded review process. Specificity, sensitivity, and accuracy for LN staging as well as LN characteristics were evaluated. Correlation with survival was investigated by Kaplan-Meier method, log-rank test and multivariate analysis., Results: 1361 patients with primary tumor of the bladder underwent RC, of which 163 (12%) patients revealed variant histologies. 65 (47.8%) patients have shown an urothelial variant (UV) and 71 (52.2%) a non-urothelial variant (NUV). LN metastases were found in 18 (27.7%) patients with UV and 21 (29.6%) patients with NUV. The accuracy to detect LN metastasis for all variant histologies was 62% with a sensitivity of 46% and a specificity of 70%. Subgroups of UV and NUV revealed an accuracy of 67% and 57%. An increased number of regional LN (HR 2.8; 1.34-6.18) and the loss of fatty hilum (HR 0.36, 0.17-0.76) were prognostic parameters. In multivariate analysis, a fatty hilum (HR 0.313, 0.104-0.945) and the presence of lymph node metastases (HR 2.866, 1.140-7.207) were prognostic., Conclusion: This first study on CT morphological behavior of variant histologies revealed an accuracy of UV and NUV comparable to UC with low specificity for all variant histologies. CT scan prior RC should be interpreted in regard to histological subtypes., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
48. [Surgical and systemic therapy of bladder cancer].
- Author
-
Ebner B, Eismann L, Volz Y, Bischoff R, Stief CG, and Schulz GB
- Subjects
- Combined Modality Therapy, Cystectomy, Humans, Rare Diseases surgery, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms surgery
- Published
- 2022
- Full Text
- View/download PDF
49. The COVID-19 pandemic - what have urologists learned?
- Author
-
Ebner B, Volz Y, Mumm JN, Stief CG, and Magistro G
- Subjects
- Androgen Antagonists, Androgens, Humans, Male, Pandemics, SARS-CoV-2, Urologists, COVID-19, Prostatic Neoplasms epidemiology
- Abstract
On 11 March 2020, the WHO declared the coronavirus disease 2019 (COVID-19) outbreak a pandemic and COVID-19 emerged as one of the biggest challenges in public health and economy in the twenty-first century. The respiratory tract has been the centre of attention, but COVID-19-associated complications affecting the genitourinary tract are reported frequently, raising concerns about possible long-term damage in these organs. The angiotensin-converting enzyme 2 (ACE2) receptor, which has a central role in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) invasion, is highly expressed in the genitourinary tract, indicating that these organs could be at a high risk of cell damage. The detection of SARS-CoV-2 in urine and semen is very rare; however, COVID-19 can manifest through urological symptoms and complications, including acute kidney injury (AKI), which is associated with poor survival, severe structural changes in testes and impairment of spermatogenesis, and hormonal imbalances (mostly secondary hypogonadism). The effect of altered total testosterone levels or androgen deprivation therapy on survival of patients with COVID-19 was intensively debated at the beginning of the pandemic; however, androgen inhibition did not show any effect in preventing or treating COVID-19 in a clinical study. Thus, urologists have a crucial role in detecting and managing damage of the genitourinary tract caused by COVID-19., (© 2022. Springer Nature Limited.)
- Published
- 2022
- Full Text
- View/download PDF
50. [Initial symptoms and diagnostics of bladder cancer].
- Author
-
Eismann L, Ebner B, Volz Y, Bischoff R, Stief CG, and Schulz GB
- Subjects
- Humans, Rare Diseases, Urinary Bladder Neoplasms diagnosis
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.